Roche's $8.3 Billion Deal For InterMune

By Peter George Psaras
Monday, August 25, 2014 10:43 AM EDT

Drug giant Roche is buying biotech firm InterMune for $8.3 billion. CNBC's Jim Cramer discusses the lifesaving drug behind the wave of M&A deals.

None.

How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.